<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Saianand Commercial Ltd has informed BSE that it does not fall under the Large Corporate category as defined by SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. This circular pertains to fund-raising through issuance of debt securities by large entities. Since the company does not qualify as a Large Corporate, it is not required to furnish Initial and Annual Disclosure for the financial year ended March 31, 2026. The filing dated April 22, 2026, is signed by Milankumar Rameshbhai Khatri, Whole-time Director. Note: The letter body incorrectly references 'The Amerise Biosciences Limited' instead of Saianand Commercial Ltd, likely a template error.
This filing confirms the company avoids additional SEBI disclosure obligations applicable to large corporates, indicating it is relatively smaller in scale. This is a routine compliance matter with no direct impact on the stock price or shareholder value in the short term.